引用本文
  • 靳令经,潘丽珍.肉毒毒素的研发及应用进展[J].同济大学学报(医学版),2019,40(5):529-534.    [点击复制]
  • JIN Ling-jing,PAN Li-zhen.Progress in research and development of botulinum toxin[J].同济大学学报(医学版),2019,40(5):529-534.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 186次   下载 204 本文二维码信息
码上扫一扫!
肉毒毒素的研发及应用进展
靳令经,潘丽珍
0
(同济大学附属同济医院神经内科,上海 200065)
摘要:
肉毒毒素(botulinum toxin, BT)是肉毒梭状芽孢杆菌在缺氧条件下产生的神经毒素,通过抑制周围神经末梢的递质释放达到化学性去神经支配作用,已广泛应用于多种疾病的治疗及医学美容等领域。近年来,随着对BT结构、作用机制及生物学特性研究的不断深入,多种各具特色的新型BT正在积极研发中,其对中枢神经系统的潜在影响亦受到越来越多的关注。原有上市药物的循证医学证据级别不断提升,新适应证层出不穷。本文就BT的基础研究及临床应用现状进行分析,为进一步开展相关研究奠定基础。
关键词:  肉毒毒素  机制  治疗  应用
DOI:10.16118/j.1008-0392.2019.05.001
投稿时间:2019-07-08
基金项目:国家重点研发计划(2018YFC1314700);上海市市级医疗卫生优秀学科带头人培养计划(2017BR029)
Progress in research and development of botulinum toxin
JIN Ling-jing,PAN Li-zhen
(Dept. of Neurology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China)
Abstract:
Botulinum toxin(BT) is produced by clostridial bacteria, which can reduce the release of neurotransmitters, inducing chemodenervation at peripheral nerve terminals. Now BT is widely used in disease treatment and medical cosmetics. With the increasing understanding of its structure, molecular mechanism and biological property, a variety of new BT products with different characteristics have been emerging and its potential effects on central nerve system are concerned. The evidence levels of market-available BT products have been upgraded and the new indications have been expanded. In this article, we review the current progress in basic research and clinical application of BT to provide new information for researchers and clinicians.
Key words:  botulinum toxin  mechanism  therapy  application

您是第2103925位访问者
版权所有《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计